| Oct 8 |
Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024
|
| Oct 1 |
Lucid Diagnostics Holds Inaugural #CheckYourFoodTube Precancer Testing Event for Former NFL Players
|
| Sep 24 |
American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test
|
| Sep 17 |
Lucid Diagnostics to be deconsolidated from PAVmed's financial statements
|
| Sep 16 |
PAVmed Announces Efforts to Regain Compliance with Nasdaq Listing Requirements
|
| Sep 10 |
Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress
|
| Sep 3 |
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health
|
| Aug 20 |
Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer
|
| Aug 14 |
PAVmed Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Aug 14 |
Q2 2024 PAVmed Inc Earnings Call
|
